Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00216671
Status:
COMPLETED
Last Update Posted:
2013-07-19
First Post:
2005-09-13
Brief Title:
Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode
Sponsor:
Janssen Pharmaceutica NV Belgium
Organization:
Janssen Pharmaceutica NV Belgium
Organization Data
Organization:
Janssen Pharmaceutica NV Belgium
Class:
INDUSTRY
Study ID:
CR002257
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen Pharmaceutica NV Belgium
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None